Medicus 2013;22(2):139-144
144
Daniela Bundalo, dr. med.
KBC Sestre milosrdnice
Klinika za psihijatriju
10000 Zagreb, Vinogradska cesta 29
e-mail:
14. 1. 2013.
January 14, 2013
12. 4. 2013.
April 12, 2013
ADRESA ZA DOPISIVANJE:
PRIMLJENO/RECEIVED:
PRIHVAĆENO/ACCEPTED:
7.
MIYAKE Y, SASAKI S, TANAKA K i sur. Osaka Maternal and
Child Health Study Group. Dietary folate and vitamins B12, B6,
and B2 intake and the risk of postpartum depression in Japan:
the Osaka Maternal and Child Health Study. J Affect Disord
2006;96:133-8.
8.
UNGERSTEDT JS, BLÖMBACK M, SÖDERSTRÖM T. Nicotin-
amide is a potent inhibitor of proinflammatory cytokines. Clin
Exp Immunol 2003;131:48-52.
9.
WYATT KM, DIMMOCK PW, JONES PW, SHAUGHN O’BRIEN
PM. Efficacy of vitamin B-6 in the treatment of premenstrual
syndrome: systematic review. BMJ 1999;318:1375-81.
10. TOLMUNEN T, VOUTILAINEN S, HINTIKKA J i sur. Dietary
folate and depressive symptoms are associated in middle-aged
Finnish men. J Nutr 2003;133:3233-6.
11. NELSON JC. The Evolving Story of Folate in Depression and
the Therapeutic Potential of l-Methylfolate. Am J Psychiatry
2012;169:1223-5.
12. FAVA M, BORUS JS, ALPERT JE, NIERENBERG AA, ROSEN-
BAUM JF, BOTTIGLIERI T. Folate, vitamin B12, and ho-
mocysteine in major depressive disorder. Am J Psychiatry
1997;154:426-8.
13. COPPEN A, BAILEY J. Enhancement of the antidepressant
action of fluoxetine by folic acid: a randomised, placebo con-
trolled trial. J Affect Disord 2000;60:121-30.
14. ALPERT JE, MISCHOULOND, RUBENSTEINGE, BOTTONARI
K, NIERENBERG AA, FAVA M. Folinic acid (Leucovorin) as an
adjunctive treatment for SSRI-refractory depression. Ann Clin
Psychiatry 2002;14:33-8.
15. ALPERT M, SILVA RR, POUGET ER. Prediction of treatment
response in geriatric depression from baseline folate level:
interaction with an SSRI or a tricyclic antidepressant. J Clin
Psychopharmacol 2003;23:309-13.
16. TAYLOR MJ, CARNEY SM, GOODWIN GM, GEDDES JR. Folate
for depressive disorders: systematic review and meta-anal-
ysis of randomized controlled trials. J Psychopharmacol
2004;18:251-6.
17. PAPAKOSTAS GI, PETERSEN T, MISCHOULON D i sur. Serum
folate, vitamin B12, and homocysteine in major depressive dis-
order, Part 1: predictors of clinical response in fluoxetine-resis-
tant depression. J Clin Psychiatry 2004;65:1090-5.
18. PAPAKOSTAS GI, PETERSEN T, MISCHOULON D i sur. Serum
folate, vitamin B12, and homocysteine in major depressive
disorder, Part 2: predictors of relapse during the continuation
phase of pharmacotherapy. J Clin Psychiatry 2004;65:1096-8.
19. JAKOVLJEVIĆ M. Biologijske teorije shizofrenije. U: Miro Ja-
kovljević. Shizofrenija u teoriji i praksi. Knjiga I. Ontologija i
klinička fenomenologija. Etiopatogeneza i klinička slika. Za-
greb: Pro Mente 2011; 65-142.
20. De HAAN L, Van AMELSVOORT T, LINSZEN DH. Elevat-
ed homocysteine levels in schizophrenia. Am J Psychiatry
2004;161:1131-2.
21. BROWN AS, BOTTIGLIERI T, SCHAEFER CA i sur. Elevated
prenatal homocysteine levels as a risk factor for schizophrenia.
Arch Gen Psychiatry 2007;64:31-9.
22. GOLIMBET VE, LEBEDEVA IS, ALFIMOVAMV i sur. Homocys-
teine-related genes and attention in patients with schizophre-
nia and schizoaffective psychosis. Zh Nevrol Psikhiatr Im S S
Korsakova 2010;110:86-9.
23. KEVERE L, PURVINA S, BAUZE D i sur. Elevated serum levels
of homocysteine as an early prognostic factor of psychiatric
disorders in children and adolescents. Schizophr Res Treat-
ment 2012;2012:373261. doi: 10.1155/2012/373261.
24. BURETIĆ-TOMLJANOVIĆ A, GIACOMETTI J, NADALIN S,
RUBESA G, VULIN M, TOMLJANOVIĆ D. Phospholipid mem-
brane abnormalities and reduced niacin skin flush response in
schizophrenia. Psychiatr Danub 2008;20:372-83.
25. McGRATH J, BROWNA, St CLAIRD. Prevention and schizophre-
nia–the role of dietary factors. Schizophr Bull 2011;37:272-83.
26. SILVER H. Vitamin B12 levels are low in hospitalized psychiat-
ric patients. Isr J Psychiatry Relat Sci 2000;37(1):41-5.
27. COOK CC, HALLWOOD PM, THOMSON AD. B Vitamin defi-
ciency and neuropsychiatric syndromes in alcohol misuse.
Alcohol 1998;33:317-36.
28. BRINAR V i sur. Neurologija za medicinare. Zagreb: Medicin-
ska naklada, 2009.
29. THOMSON AD, GUERRINI I, MARSHALL EJ, Wernicke’s En-
cephalopathy: Role of Thiamine. Practical Gastroenterology
2009;33:21-30.
30. ZUBARAN C, FERNANDES JG, RODNIGHT R. Wernicke-Kor-
sakoff syndrome. Postgrad Med J 1997;73:27-31.
31. GALVIN R, BRÅTHEN G, IVASHYNKA A, HILLBOM M, TA-
NASESCU R, LEONE MA. EFNS guidelines for diagnosis, ther-
apy and prevention of Wernicke encephalopathy. Eur J Neurol
2010;17:1408-18.
BundaloD., Srkalović Imširagić A.
